Process for the manufacture of structured materials using nano-fibrillar cellulose gels
US-2018327971-A1 · Nov 15, 2018 · US
US11511015B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11511015-B2 |
| Application number | US-201616065233-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 30, 2016 |
| Priority date | Dec 31, 2015 |
| Publication date | Nov 29, 2022 |
| Grant date | Nov 29, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present application provides a medical multi-layer product comprising a layer comprising nanofibrillar cellulose, and a layer of gauze. The present application also provides a medical product comprising the medical multi-layer product, and a cosmetic product comprising the medical multi-layer product. The present application also provides a method for preparing a medical multi-layer product, the method comprising providing a filter, providing a dispersion comprising nanofibrillar cellulose, providing a gauze, applying the dispersion onto the filter, applying the gauze onto the dispersion, and dewatering the structure through the filter to obtain the medical multi-layer product.
Opening claim text (preview).
The invention claimed is: 1. A medical multi-layer product comprising a first layer comprising plant nanofibrillar cellulose having a moisture content in the range of 0-10% (w/w), and a layer of gauze; wherein the product has a tear index in the range of 18-100 mNm 2 /q. 2. The medical multi-layer product of claim 1 , wherein the first layer comprising plant nanofibrillar cellulose has a moisture content in the range of 5-7% (w/w). 3. The medical multi-layer product of claim 1 , comprising a second layer comprising nanofibrillar cellulose. 4. The medical multi-layer product of claim 3 , wherein the plant nanofibrillar cellulose in the first layer and/or in the second layer, when dispersed in water, provides a Brookfield viscosity of at least 2000 mPa·s, measured at a consistency of 0.8% (w/w) and at 10 rpm. 5. The medical multi-layer product of claim 1 , wherein the gauze comprises natural gauze. 6. The medical multi-layer product of claim 1 , wherein the gauze comprises synthetic gauze or semi-synthetic. 7. The medical multi-layer product of claim 1 , wherein the plant nanofibrillar cellulose comprises non-modified nanofibrillar cellulose. 8. The medical multi-layer product of claim 1 , wherein the plant nanofibrillar cellulose comprises chemically modified plant nanofibrillar cellulose. 9. The medical multi-layer product of claim 1 , wherein a layer of plant nanofibrillar cellulose has a thickness in the range of 5-60 μm. 10. The medical multi-layer product of claim 1 , having a thickness in the range of 100-500 μm. 11. The medical multi-layer product of claim 1 , wherein the first layer comprising t nanofibrillar cellulose comprises an amount of non-nanofibrillar pulp in the range of 0.1-60% (w/w) of total cellulose in said layer. 12. The medical multi-layer product of claim 1 , wherein product has a grammage in the range of 50-100 g/m 2 . 13. The medical multi-layer product of claim 1 wherein the product has a density in the range of 300-800 kg/m 3 . 14. The medical multi-layer product of claim 1 , wherein the plant nanofibrillar cellulose in the first layer has a number average diameter of a fibril in the range of 1-100 nanometers. 15. The medical multi-layer product of claim 1 comprising a therapeutic agent. 16. The medical multi-layer product of claim 1 comprising a cosmetic agent. 17. A medical product comprising the medical multi-layer product of claim 1 . 18. A method for treating skin wounds or other damages or injuries, the method comprising applying the medical multi-layer product of claim 1 onto the wound, damage, or injury. 19. A method for treating skin wounds covered with a graft the method comprising applying the medical multi-layer product of claim 1 onto the graft. 20. A method for administering therapeutic agent, the method comprising applying the medical multi-layer product of claim 15 onto skin. 21. A method for preparing a medical multi-layer product, the method comprising providing a filter, providing a dispersion comprising plant nanofibrillar cellulose, providing a gauze, applying the dispersion onto the filter, applying the gauze onto the dispersion to form a structure, and dewatering the structure through the filter to obtain the medical multi-layer product comprising a first layer comprising plant nanofibrillar cellulose having a moisture content in the range of 0-10% (w/w). 22. The method of claim 21 , further comprising providing a second dispersion comprising nanofibrillar cellulose and applying the second dispersion comprising nanofibrillar cellulose onto the gauze. 23. A medical multi-layer product comprising a first layer comprising plant nanofibrillar cellulose having a moisture content in the range of 0-10% (w/w), and a layer of gauze; wherein the product has a tear index in the range of 18-100 mNm 2 /g, and wherein the product is obtained with the method of claim 21 . 24. A method for preparing a medical multi-layer product, the method comprising providing a first layer comprising plant nanofibrillar cellulose having a moisture content in the range of 0-10% (w/w), providing a layer of gauze, and laminating the first layer comprising plant nanofibrillar cellulose and the layer of gauze to obtain the medical multi-layer product; wherein the product has a tear index in the range of 18-100 mNm 2 /q. 25. The method of claim 24 , wherein the first layer comprising plant nanofibrillar cellulose has a moisture content in the range of 1-10%. 26. The method of claim 24 , wherein the gauze comprises natural gauze. 27. The method of claim 24 , wherein the gauze comprises synthetic gauze or semi-synthetic. 28. The method of claim 24 , wherein the plant nanofibrillar cellulose in the first layer comprising plant nanofibrillar cellulose when dispersed in water, provides a Brookfield viscosity of at least 2000 mPa·s, measured at a consistency of 0.8% (w/w) and at 10 rpm. 29. The method of claim 24 , wherein the first layer comprising plant nanofibrillar cellulose comprises non-modified plant nanofibrillar cellulose. 30. The method of claim 24 , wherein the first layer comprising plant nanofibrillar cellulose comprises chemically modified plant nanofibrillar cellulose. 31. The method of claim 24 , wherein the first layer comprising plant nanofibrillar cellulose comprises an amount of non-nanofibrillar pulp in the range of 0.1-60% (w/w) of total cellulose in said layer. 32. The method of claim 24 , comprising providing a therapeutic agent and including the therapeutic agent to the first layer comprising plant nanofibrillar cellulose. 33. The method of claim 24 , comprising providing a cosmetic agent and including the cosmetic agent to the first layer comprising plant nanofibrillar cellulose.
Liquid-swellable gel-forming materials, e.g. super-absorbents · CPC title
Materials for use in artificial skin · CPC title
Polysaccharides · CPC title
Apparatus or processes for manufacturing non-adhesive dressings or bandages · CPC title
Polysaccharides or their derivatives {(A61L15/225 takes precedence)} · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.